These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 24444286

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Distribution of a vaginal gel (Invisible Condom) before, during and after simulated sexual intercourse and its persistence when delivered by two different vaginal applicators: a magnetic resonance imaging study.
    Omar RF, Trottier S, Brousseau G, Lamarre A, Alexandre Gagnon, Bergeron MG.
    Contraception; 2008 Jun; 77(6):447-55. PubMed ID: 18477496
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A randomized trial to determine the distribution of four topical gel formulations in the human vagina.
    Barnhart K, Kulp JL, Rosen M, Shera DM.
    Contraception; 2009 Apr; 79(4):297-303. PubMed ID: 19272499
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A randomized, double-blind, placebo-controlled safety and acceptability study of two Invisible Condom formulations in women from Cameroon.
    Mbopi-Keou FX, Trottier S, Omar RF, Nkele NN, Fokoua S, Mbu ER, Giguere JF, Domingo MC, Piret J, Tsague L, Zekeng L, Mwatha A, Mâsse B, Bergeron MG.
    Contraception; 2009 Nov; 80(5):484-92. PubMed ID: 19835725
    [Abstract] [Full Text] [Related]

  • 7. Design aspects of vaginal applicators that influence acceptance among target users.
    Bakke AJ, Zaveri T, Higgins MJ, Ziegler GR, Hayes JE.
    Sci Rep; 2021 May 07; 11(1):9802. PubMed ID: 33963262
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A Randomized Crossover Study Evaluating the Use and Acceptability of the SILCS Diaphragm Compared to Vaginal Applicators for Vaginal Gel Delivery.
    Beksinska M, Greener R, Smit J, Maphumulo B, Mphili N, Kilbourne-Brook M, Coffey PS.
    AIDS Behav; 2018 Jan 07; 22(1):127-132. PubMed ID: 28993940
    [Abstract] [Full Text] [Related]

  • 12. A Pilot Study Measuring the Distribution and Permeability of a Vaginal HIV Microbicide Gel Vehicle Using Magnetic Resonance Imaging, Single Photon Emission Computed Tomography/Computed Tomography, and a Radiolabeled Small Molecule.
    Fuchs EJ, Schwartz JL, Friend DR, Coleman JS, Hendrix CW.
    AIDS Res Hum Retroviruses; 2015 Nov 07; 31(11):1109-15. PubMed ID: 26077739
    [Abstract] [Full Text] [Related]

  • 13. Optimizing packing contrast for MRI-based intracavitary brachytherapy planning for cervical cancer.
    Swanick CW, Castle KO, Rechner LA, Rauch GM, Jhingran A, Eifel PJ, Klopp AH.
    Brachytherapy; 2015 Nov 07; 14(3):385-9. PubMed ID: 25620163
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Acceptability of a non-woven device for vaginal drug delivery of microbicides or other active agents.
    Joanis CL, Hart CW.
    AIDS Behav; 2010 Jun 07; 14(3):600-6. PubMed ID: 20049522
    [Abstract] [Full Text] [Related]

  • 16. Couples' acceptability of the SILCS diaphragm for microbicide delivery.
    Frezieres RG, Walsh T, Kilbourne-Brook M, Coffey PS.
    Contraception; 2012 Jan 07; 85(1):99-107. PubMed ID: 22067809
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.